CTCF/NN
,/,
Cohesin/NN
,/,
and/CC
Chromatin/NN
in/IN
Human/JJ
Cancer/NN
./.
====================
It/PRP
is/VBZ
becoming/VBG
increasingly/RB
clear/JJ
that/IN
eukaryotic/JJ
genomes/NNS
are/VBP
subjected/VBN
to/TO
higher-order/JJ
chromatin/NN
organization/NN
by/IN
the/DT
CCCTC-binding/JJ
factor/cohesin/NN
complex/NN
./.
====================
Their/PRP$
dynamic/JJ
interactions/NNS
in/IN
three/CD
dimensions/NNS
within/IN
the/DT
nucleus/NN
regulate/VBP
gene/NN
transcription/NN
by/IN
changing/VBG
the/DT
chromatin/NN
architecture/NN
./.
====================
Such/JJ
spatial/JJ
genomic/JJ
organization/NN
is/VBZ
functionally/RB
important/JJ
for/IN
the/DT
spatial/JJ
disposition/NN
of/IN
chromosomes/NNS
to/TO
control/VB
cell/NN
fate/NN
during/IN
development/NN
and/CC
differentiation/NN
./.
====================
Thus/RB
,/,
the/DT
dysregulation/NN
of/IN
proper/JJ
long-range/JJ
chromatin/NN
interactions/NNS
may/MD
influence/VB
the/DT
development/NN
of/IN
tumorigenesis/NN
and/CC
cancer/NN
progression/NN
./.
====================
Genomes/NNS
form/VBP
higher-order/JJ
chromatin/NN
structures/NNS
during/IN
cellular/JJ
development/NN
and/CC
differentiation/NN
[/(
1–4/CD
]/)
./.
====================
The/DT
spatial/JJ
folding/VBG
of/IN
chromosomes/NNS
and/CC
their/PRP$
organization/NN
in/IN
the/DT
nucleus/NN
have/VBP
profound/VBN
effects/NNS
on/IN
gene/NN
expression/NN
[/(
5/CD
,/,
6/CD
]/)
./.
====================
It/PRP
is/VBZ
now/RB
well/RB
established/VBN
that/IN
chromosomal/JJ
architecture/NN
is/VBZ
largely/RB
mediated/VBN
by/IN
the/DT
CCCTC-binding/JJ
factor/NN
(/(
CTCF/NN
)/)
/cohesin/NN
complex/NN
[/(
7/CD
,/,
8/CD
]/)
./.
====================
CTCF/NN
,/,
a/DT
zinc/NN
finger/NN
DNA-binding/JJ
protein/NN
that/WDT
functions/VBZ
in/IN
transcriptional/JJ
repression/NN
,/,
activation/NN
,/,
and/CC
as/IN
an/DT
insulator/NN
that/DT
interferes/VBZ
with/IN
enhancer–promoter/NN
interactions/NNS
[/(
9/CD
]/)
,/,
is/VBZ
needed/VBN
for/IN
the/DT
recruitment/NN
of/IN
cohesin/NN
to/TO
chromatin/NN
[/(
10/CD
]/)
./.
====================
In/IN
addition/NN
to/TO
its/PRP$
major/JJ
influence/NN
on/IN
sister/NN
chromatid/NN
cohesion/NN
[/(
11/CD
]/)
,/,
cohesin/NN
affects/VBZ
gene/NN
transcription/NN
by/IN
facilitating/VBG
long-range/RB
interactions/NNS
between/IN
members/NNS
of/IN
many/JJ
developmentally/RB
regulated/VBN
gene/NN
families/NNS
[/(
12–14/CD
]/)
./.
====================
Interphase/NN
chromosomes/NNS
of/IN
higher/JJR
eukaryotes/VBZ
are/VBP
subdivided/VBN
into/IN
evolutionarily/RB
conserved/VBN
topologically/RB
associated/VBN
domains/NNS
(/(
TADs/NNS
)/)
in/IN
the/DT
three-dimensional/JJ
space/NN
of/IN
the/DT
nucleus/NN
(/(
Fig/NN
./.
====================
1/CD
)/)
[/(
15/CD
,/,
16/CD
]/)
./.
====================
TADs/NNS
are/VBP
defined/VBN
as/IN
self-associating/JJ
chromosome/NN
segments/NNS
enclosed/VBN
by/IN
a/DT
chromatin/NN
loop/NN
in/IN
the/DT
megabase/NN
range/NN
detected/VBN
by/IN
Hi-C/NN
methods/NNS
[/(
17/CD
]/)
./.
====================
TADs/NNS
show/VBP
a/DT
high/JJ
frequency/NN
of/IN
interactions/NNS
within/IN
domains/NNS
and/CC
a/DT
low/JJ
frequency/NN
of/IN
interactions/NNS
among/IN
different/JJ
domains/NNS
[/(
15/CD
,/,
17/CD
]/)
./.
====================
They/PRP
are/VBP
partitioned/VBN
into/IN
several/JJ
subcompartments/NNS
related/JJ
to/TO
their/PRP$
gene/NN
expression/NN
patterns/NNS
and/CC
maintained/VBD
across/IN
cell/NN
types/NNS
,/,
suggesting/VBG
that/IN
TADs/NNS
shape/VBP
the/DT
regulatory/JJ
landscape/NN
of/IN
the/DT
genome/NN
during/IN
development/NN
[/(
6/CD
,/,
15/CD
,/,
16/CD
]/)
./.
====================
Interestingly/RB
,/,
in/IN
the/DT
boundaries/NNS
of/IN
TADs/NNS
,/,
there/EX
is/VBZ
an/DT
abundance/NN
of/IN
the/DT
architectural/JJ
protein/NN
CTCF/NN
and/CC
cohesin/NN
[/(
6/CD
,/,
15/CD
]/)
,/,
suggesting/VBG
that/IN
these/DT
proteins/NNS
have/VBP
a/DT
role/NN
in/IN
establishing/VBG
the/DT
topological/JJ
boundaries/NNS
[/(
17/CD
]/)
./.
====================
Increasing/VBG
evidence/NN
from/IN
recent/JJ
studies/NNS
has/VBZ
indicated/VBN
that/IN
genomic/JJ
instability/NN
is/VBZ
spatially/RB
related/JJ
to/TO
higher-order/JJ
chromatin/NN
organization/NN
in/IN
cancer/NN
cells/NNS
[/(
18/CD
]/)
./.
====================
Previous/JJ
studies/NNS
of/IN
c-Myc/NN
,/,
BCL/NN
,/,
and/CC
immunoglobulin/NN
heavy-chain/JJ
(/(
Igh/JJ
)/)
(/(
the/DT
most/JJS
common/JJ
translocation/NN
partners/NNS
in/IN
various/JJ
B-cell/NN
lymphomas/NNS
)/)
showed/VBD
that/IN
these/DT
loci/NNS
are/VBP
preferentially/RB
localized/VBD
in/IN
close/JJ
spatial/JJ
juxtaposition/NN
to/TO
each/DT
other/JJ
in/IN
normal/JJ
B/NN
cells/NNS
[/(
19/CD
,/,
20/CD
]/)
./.
====================
Moreover/RB
,/,
the/DT
boundaries/NNS
of/IN
copy-number/NN
alterations/NNS
are/VBP
preferentially/RB
localized/VBD
in/IN
close/JJ
spatial/JJ
juxtaposition/NN
within/IN
the/DT
nucleus/NN
[/(
21–23/CD
]/)
./.
====================
Thus/RB
,/,
the/DT
continuous/JJ
DNA/NN
damage/NN
and/CC
subsequent/JJ
defective/JJ
repair/NN
near/JJ
double-strand/JJ
break/NN
(/(
DSB/NN
)/)
sites/NNS
might/MD
generate/VB
copy-number/NN
alterations/NNS
of/IN
oncogenes/NNS
during/IN
tumorigenesis/NN
[/(
24/CD
,/,
25/CD
]/)
./.
====================
In/IN
addition/NN
,/,
the/DT
recent/JJ
discovery/NN
that/DT
DSBs/NNS
and/CC
subsequent/JJ
amplification/NN
of/IN
estrogen/NN
response/NN
elements/NNS
can/MD
be/VB
generated/VBN
by/IN
estrogen-induced/JJ
long-range/RB
chromatin/NN
interactions/NNS
in/IN
breast/NN
cancer/NN
[/(
26/CD
]/)
further/RBR
indicates/VBZ
the/DT
importance/NN
of/IN
higher-order/JJ
genome/NN
architecture/NN
for/IN
chromosomal/JJ
rearrangement/NN
./.
====================
Therefore/RB
,/,
the/DT
close/JJ
spatial/JJ
proximity/NN
of/IN
genomic/JJ
regions/NNS
may/MD
provide/VB
an/DT
opportunity/NN
for/IN
the/DT
formation/NN
of/IN
specific/JJ
,/,
cancer-related/VBD
chromosomal/JJ
translocation/NN
events/NNS
during/IN
tumor/NN
development/NN
[/(
18/CD
,/,
27/CD
,/,
28/CD
]/)
./.
====================
Here/RB
,/,
we/PRP
briefly/RB
review/NN
recent/JJ
works/NNS
on/IN
the/DT
roles/NNS
of/IN
CTCF/NN
and/CC
cohesin/NN
in/IN
genome/NN
folding/VBG
,/,
their/PRP$
global/JJ
impact/NN
on/IN
gene/NN
expression/NN
,/,
and/CC
their/PRP$
association/NN
with/IN
human/JJ
disease/NN
./.
====================
CTCF/NN
====================
Chromatin/NN
organizer/NN
roles/NNS
of/IN
CTCF/NN
====================
CTCF/NN
is/VBZ
a/DT
sequence-specific/JJ
DNA-binding/JJ
protein/NN
that/WDT
functions/VBZ
by/IN
utilizing/VBG
an/DT
11-zinc-finger/NN
domain/NN
[/(
29/CD
]/)
./.
====================
Because/IN
CTCF/NN
was/VBD
first/JJ
identified/VBD
at/IN
the/DT
5′/JJ
and/CC
3′/CD
ends/NNS
of/IN
the/DT
chicken/NN
β-globin/NN
locus/NN
[/(
30/CD
]/)
and/CC
the/DT
imprinted/JJ
Igf2/H19/NN
locus/NN
[/(
31/CD
,/,
32/CD
]/)
,/,
it/PRP
is/VBZ
known/VBN
as/IN
an/DT
insulator/NN
protein/NN
that/WDT
can/MD
block/VB
enhancer/NN
activity/NN
in/IN
eukaryotes/NNS
[/(
32/CD
]/)
./.
====================
Although/IN
insulators/NNS
would/MD
be/VB
expected/VBN
to/TO
be/VB
located/JJ
in/IN
intergenic/JJ
regions/NNS
where/WRB
they/PRP
could/MD
act/VB
as/IN
barriers/NNS
to/TO
block/VB
enhancer/NN
activity/NN
[/(
30/CD
]/)
,/,
genome-wide/NN
analysis/NN
indicated/VBD
that/IN
CTCF-binding/JJ
sites/NNS
are/VBP
present/JJ
in/IN
genes/NNS
and/or/CC
promoter/NN
regions/NNS
as/IN
well/RB
as/IN
intergenic/JJ
regions/NNS
[/(
10/CD
,/,
33/CD
]/)
./.
====================
More/RBR
recent/JJ
evidence/NN
revealed/VBD
that/IN
almost/RB
15/CD
%/NN
of/IN
CTCF-recognition/NN
sites/NNS
are/VBP
located/JJ
near/JJ
promoters/NNS
and/CC
~40/CD
%/NN
are/VBP
within/IN
exons/NNS
and/CC
introns/NNS
[/(
17/CD
]/)
,/,
suggesting/VBG
that/IN
CTCF/NN
has/VBZ
dynamic/JJ
roles/NNS
other/JJ
than/IN
enhancer/NN
blocking/VBG
activity/NN
./.
====================
While/IN
earlier/RBR
studies/NNS
implied/VBD
that/DT
the/DT
distribution/NN
patterns/NNS
of/IN
CTCF/NN
are/VBP
similar/JJ
to/TO
those/DT
of/IN
transcription/NN
activators/NNS
or/CC
repressors/NNS
,/,
recently/RB
determined/VBN
global/JJ
distribution/NN
patterns/NNS
suggested/VBD
that/IN
CTCF-binding/JJ
sites/NNS
are/VBP
not/RB
strongly/RB
correlated/VBD
with/IN
general/JJ
transcription/NN
factor/NN
occupancy/NN
[/(
10/CD
]/)
./.
====================
Moreover/RB
,/,
depletion/NN
of/IN
CTCF/NN
altered/JJ
its/PRP$
histone/NN
acetylation/NN
and/CC
methylation/NN
profiles/NNS
in/IN
the/DT
β-globin/NN
locus/NN
,/,
but/CC
did/VBD
not/RB
significantly/RB
affect/VB
β-globin/NN
expression/NN
[/(
34/CD
,/,
35/CD
]/)
,/,
suggesting/VBG
that/IN
CTCF/NN
has/VBZ
a/DT
role/NN
distinct/JJ
from/IN
that/DT
of/IN
traditional/JJ
regulatory/JJ
proteins/NNS
./.
====================
Interestingly/RB
,/,
CTCF/NN
has/VBZ
been/VBN
shown/VBN
to/TO
serve/VB
as/IN
a/DT
chromatin/NN
organizer/NN
complex/NN
by/IN
linking/VBG
chromosomal/JJ
domains/NNS
in/IN
the/DT
mouse/human/JJ
β-globin/NN
cluster/NN
(/(
Fig/NN
./.
====================
2/CD
)/)
[/(
36/CD
,/,
37/CD
]/)
./.
====================
During/IN
erythroid/JJ
differentiation/NN
,/,
CTCF/NN
is/VBZ
recruited/VBN
and/CC
enables/VBZ
enhancers/NNS
to/TO
physically/RB
access/VBP
promoters/NNS
of/IN
β-globin/NN
,/,
which/WDT
both/CC
influences/VBZ
transcription/NN
and/CC
contributes/VBZ
to/TO
cell-type-specific/JJ
chromatin/NN
organization/NN
and/CC
function/NN
[/(
36/CD
,/,
37/CD
]/)
./.
====================
Similarly/RB
,/,
long-range/RB
interactions/NNS
associated/VBN
with/IN
CTCF/NN
have/VBP
been/VBN
observed/VBN
within/IN
mammalian/JJ
gene/NN
loci/NNS
including/VBG
the/DT
Igf2/H19/NN
imprinted/JJ
control/NN
region/NN
[/(
38/CD
,/,
39/CD
]/)
,/,
the/DT
α-globin/NN
gene/NN
cluster/NN
in/IN
erythroid/JJ
cells/NNS
[/(
40/CD
]/)
,/,
and/CC
the/DT
Igh/JJ
locus/NN
in/IN
B/NN
cells/NNS
[/(
41/CD
]/)
./.
====================
DNA/NN
methylation/NN
and/CC
CTCF/NN
binding/NN
====================
It/PRP
has/VBZ
been/VBN
known/VBN
for/IN
many/JJ
years/NNS
that/WDT
CTCF/NN
binding/NN
is/VBZ
abolished/VBN
by/IN
the/DT
DNA/NN
methylation/NN
of/IN
CpG/NN
sites/NNS
within/IN
the/DT
CTCF/NN
motif/NN
[/(
32/CD
]/)
./.
====================
At/IN
the/DT
imprinted/JJ
Igf2/H19/NN
locus/NN
,/,
CTCF/NN
binds/VBZ
specifically/RB
to/TO
the/DT
unmethylated/JJ
differentially/RB
methylated/VBN
region/NN
(/(
DMR/NN
)/)
,/,
which/WDT
is/VBZ
required/VBN
for/IN
the/DT
expression/NN
of/IN
H19/NN
on/IN
the/DT
maternal/JJ
chromosome/NN
(/(
Fig/NN
./.
====================
3A/NN
)/)
[/(
32/CD
,/,
42/CD
]/)
./.
====================
However/RB
,/,
on/IN
the/DT
paternal/JJ
allele/NN
,/,
the/DT
methylated/JJ
DMR/NN
prohibits/VBZ
CTCF/NN
enrichment/JJ
and/CC
leads/VBZ
to/TO
IGF2/NN
expression/NN
[/(
30/CD
,/,
42/CD
]/)
,/,
suggesting/VBG
methylation-sensitive/JJ
binding/NN
of/IN
CTCF/NN
at/IN
the/DT
target/NN
region/NN
./.
====================
Interestingly/RB
,/,
genome-wide/NN
association/NN
studies/NNS
have/VBP
identified/VBN
that/WDT
only/RB
a/DT
small/JJ
subset/NN
of/IN
CTCF-binding/JJ
sites/NNS
are/VBP
sensitive/JJ
to/TO
the/DT
methylation/NN
status/NN
of/IN
DNA/NN
[/(
8/CD
,/,
43/CD
]/)
./.
====================
Abnormal/JJ
DNA/NN
methylation/NN
patterns/NNS
of/IN
CTCF-binding/JJ
sites/NNS
are/VBP
associated/VBN
with/IN
transcriptional/JJ
regulation/NN
of/IN
tumor/NN
suppressor/NN
or/CC
oncogenic/JJ
genes/NNS
in/IN
several/JJ
human/JJ
cancers/NNS
[/(
44/CD
]/)
./.
====================
CTCF/NN
plays/VBZ
an/DT
essential/JJ
role/NN
in/IN
maintaining/VBG
INK/ARF/NN
gene/NN
expression/NN
and/CC
disruption/NN
of/IN
its/PRP$
binding/NN
by/IN
DNA/NN
methylation/NN
contributes/VBZ
to/TO
the/DT
epigenetic/JJ
silencing/NN
of/IN
INK/ARF/NN
genes/NNS
in/IN
human/JJ
breast/NN
cancer/NN
cells/NNS
[/(
45/CD
,/,
46/CD
]/)
./.
====================
Epigenetic/JJ
inactivation/NN
of/IN
RASSF1A/NN
and/CC
CDH1/NN
also/RB
correlates/VBZ
with/IN
the/DT
epigenetic/JJ
alteration/NN
of/IN
CTCF-recognition/NN
sites/NNS
in/IN
human/JJ
breast/NN
cancer/NN
[/(
46/CD
]/)
./.
====================
Conversely/RB
,/,
in/IN
one/CD
study/NN
,/,
aberrant/JJ
DNA/NN
methylation/NN
led/VBD
to/TO
the/DT
prevention/NN
of/IN
CTCF-mediated/JJ
silencing/NN
of/IN
the/DT
BCL6/NN
gene/NN
,/,
thus/RB
increasing/VBG
oncogenic/JJ
BCL6/NN
expression/NN
in/IN
lymphoma/NN
[/(
47/CD
]/)
./.
====================
The/DT
concept/NN
that/IN
the/DT
methylation-sensitive/JJ
binding/NN
of/IN
CTCF/NN
controls/NNS
gene/NN
expression/NN
by/IN
changing/VBG
the/DT
chromatin/NN
architecture/NN
has/VBZ
been/VBN
supported/VBN
by/IN
the/DT
finding/NN
that/DT
CTCF/NN
alters/VBZ
the/DT
chromatin/NN
architecture/NN
[/(
8/CD
]/)
./.
====================
For/IN
instance/NN
,/,
in/IN
the/DT
Igf2/H19/NN
locus/NN
,/,
Igf2/NN
imprinting/VBG
on/IN
the/DT
maternal/JJ
allele/NN
is/VBZ
performed/VBN
by/IN
perturbing/VBG
the/DT
proper/JJ
long-range/RB
chromatin/NN
interactions/NNS
between/IN
the/DT
Igf2/NN
gene/NN
and/CC
a/DT
distal/JJ
enhancer/NN
through/IN
the/DT
formation/NN
of/IN
chromatin/NN
loops/NNS
mediated/VBN
by/IN
CTCF/NN
(/(
Fig/NN
./.
====================
3A/NN
)/)
[/(
38/CD
,/,
39/CD
]/)
./.
====================
However/RB
,/,
on/IN
the/DT
paternal/JJ
chromosome/NN
,/,
CTCF/NN
enrichment/JJ
at/IN
the/DT
DMR/NN
and/CC
insulator/NN
looping/VBG
are/VBP
prevented/VBN
by/IN
DNA/NN
methylation/NN
,/,
thus/RB
ensuring/VBG
physical/JJ
interaction/NN
between/IN
the/DT
Igf2/NN
gene/NN
and/CC
the/DT
distal/JJ
enhancer/NN
and/CC
inducing/VBG
the/DT
exclusive/JJ
expression/NN
of/IN
the/DT
paternal/JJ
allele/NN
./.
====================
Similarly/RB
,/,
nucleotide/NN
excision/NN
repair/NN
factor-mediated/JJ
DNA/NN
demethylation/NN
at/IN
the/DT
promoter/NN
region/NN
induces/VBZ
the/DT
enrichment/JJ
of/IN
CTCF/NN
and/CC
consequently/RB
the/DT
formation/NN
of/IN
a/DT
looping/JJ
structure/NN
and/CC
controls/VBZ
gene/NN
expression/NN
at/IN
the/DT
RARβ2/NN
locus/NN
[/(
48/CD
]/)
./.
====================
We/PRP
also/RB
found/VBD
that/IN
epigenetic/JJ
silencing/NN
of/IN
PTGS2/NN
correlates/VBZ
with/IN
the/DT
loss/NN
of/IN
CTCF/NN
binding/NN
by/IN
DNA/NN
methylation/NN
at/IN
the/DT
promoter/NN
region/NN
,/,
thereby/RB
producing/VBG
an/DT
inappropriate/JJ
higher-order/JJR
chromatin/NN
structure/NN
in/IN
human/JJ
gastric/JJ
cancer/NN
cells/NNS
(/(
Fig/NN
./.
====================
3B/NN
)/)
[/(
49/CD
]/)
./.
====================
Somatic/JJ
mutations/NNS
at/IN
CTCF-binding/NN
sites/NNS
====================
In/IN
several/JJ
studies/NNS
,/,
somatic/JJ
mutations/NNS
at/IN
the/DT
coding/VBG
region/NN
of/IN
the/DT
CTCF/NN
gene/NN
were/VBD
detected/VBN
in/IN
acute/JJ
leukemia/NN
and/CC
individuals/NNS
with/IN
intellectual/JJ
disability/NN
[/(
50–52/CD
]/)
./.
====================
However/RB
,/,
a/DT
high/JJ
frequency/NN
of/IN
recurrent/JJ
mutations/NNS
in/IN
the/DT
CTCF-binding/JJ
site/NN
has/VBZ
been/VBN
more/RBR
profoundly/RB
found/VBN
in/IN
human/JJ
cancer/NN
[/(
53/CD
]/)
./.
====================
Unsurprisingly/RB
,/,
single-nucleotide/JJ
polymorphisms/NNS
also/RB
confer/VBP
disease/NN
susceptibility/NN
in/IN
humans/NNS
by/IN
decreasing/VBG
the/DT
methylation/NN
level/NN
at/IN
differentially/RB
methylated/VBN
CTCF-binding/NN
sites/NNS
such/JJ
as/IN
rs2334499/NN
in/IN
the/DT
11p15/NN
region/NN
[/(
54/CD
]/)
./.
====================
Since/IN
genetic/JJ
and/or/CC
epigenetic/JJ
alterations/NNS
frequently/RB
occur/VBP
in/IN
the/DT
CTCF/NN
anchor/NN
region/NN
in/IN
various/JJ
human/JJ
cancers/NNS
[/(
7/CD
,/,
8/CD
,/,
55/CD
]/)
,/,
these/DT
mutations/NNS
can/MD
influence/VB
gene/NN
expression/NN
and/CC
tumor/NN
progression/NN
by/IN
abrogating/VBG
the/DT
CTCF-mediated/JJ
spatial/JJ
folding/VBG
of/IN
chromosomes/NNS
[/(
56/CD
]/)
./.
====================
Architectural/JJ
role/NN
of/IN
CTCF/NN
====================
There/EX
is/VBZ
direct/JJ
evidence/NN
that/IN
CTCF/NN
can/MD
physically/RB
interact/VBP
with/IN
other/JJ
transcriptional/JJ
regulators/NNS
,/,
such/JJ
as/IN
the/DT
zinc/NN
finger/NN
protein/NN
Yin/NN
Yang/NN
1/CD
(/(
YY1/NN
)/)
,/,
as/IN
an/DT
X/NN
chromosome/NN
binary/NN
switch/NN
[/(
57/CD
]/)
./.
====================
CTCF/NN
also/RB
forms/VBZ
a/DT
complex/NN
with/IN
the/DT
SNF2-like/JJ
chromodomain/NN
helicase/NN
protein/NN
(/(
CHD8/NN
)/)
[/(
58/CD
]/)
and/CC
the/DT
methyl-CpG–binding/JJ
protein/NN
Kaiso/NN
[/(
59/CD
]/)
through/IN
the/DT
zinc-finger/NN
domain/NN
[/(
10/CD
]/)
./.
====================
Thus/RB
,/,
CHD8/NN
enhances/VBZ
insulator/NN
activity/NN
,/,
whereas/IN
Kaiso/NN
has/VBZ
a/DT
negative/JJ
effect/NN
on/IN
the/DT
CTCF-mediated/JJ
enhancer/NN
blocking/VBG
activity/NN
[/(
58/CD
,/,
59/CD
]/)
./.
====================
Interestingly/RB
,/,
the/DT
C-terminus/NN
of/IN
CTCF/NN
preferentially/RB
interacts/VBZ
with/IN
the/DT
STAG1/NN
or/CC
STAG2/NN
subunit/NN
of/IN
cohesin/NN
[/(
60/CD
]/)
./.
====================
Furthermore/RB
,/,
recent/JJ
genome-wide/NN
studies/NNS
mapping/VBG
the/DT
binding/NN
sites/NNS
of/IN
CTCF/NN
revealed/VBD
that/IN
CTCF/NN
often/RB
colocalizes/VBZ
with/IN
the/DT
cohesin/NN
complex/NN
throughout/IN
the/DT
genome/NN
[/(
61–63/CD
]/)
./.
====================
Thus/RB
,/,
CTCF/NN
is/VBZ
generally/RB
thought/VBN
to/TO
be/VB
required/VBN
for/IN
the/DT
localization/NN
of/IN
cohesin/NN
at/IN
its/PRP$
binding/NN
sites/NNS
[/(
64/CD
]/)
./.
====================
The/DT
cohesin/NN
complex/NN
====================
Cohesin/NN
as/IN
a/DT
sister/NN
chromatid/NN
cohesion/NN
molecule/NN
====================
Cohesin/NN
,/,
a/DT
large/JJ
ring-shaped/JJ
molecule/NN
that/IN
can/MD
bind/VB
DNA/NN
strands/NNS
,/,
is/VBZ
a/DT
multi-subunit/JJ
protein/NN
complex/NN
composed/VBN
of/IN
two/CD
structural/JJ
maintenance/NN
of/IN
chromosomes/NNS
(/(
SMC/NNS
)/)
molecules/NNS
,/,
SMC1/NN
and/CC
SMC3/NN
,/,
either/CC
stromal/JJ
antigen/NN
(/(
STAG/NN
)/)
STAG1/NN
or/CC
STAG2/NN
,/,
and/CC
the/DT
kleisin/NN
subunit/NN
RAD21/NN
(/(
Fig/NN
./.
====================
4/CD
)/)
[/(
9/CD
]/)
./.
====================
Cohesin/NN
is/VBZ
required/VBN
to/TO
mediate/VB
sister/JJ
chromatid/NN
cohesion/NN
for/IN
proper/JJ
chromosome/NN
segregation/NN
in/IN
the/DT
S/NN
phase/NN
until/IN
cell/NN
division/NN
[/(
65/CD
]/)
./.
====================
The/DT
cohesin/NN
complex/NN
was/VBD
also/RB
found/VBD
to/TO
be/VB
involved/VBN
in/IN
efficient/JJ
DNA/NN
DSB/NN
repair/NN
[/(
64/CD
]/)
./.
====================
Since/IN
cohesin/NN
is/VBZ
important/JJ
for/IN
holding/VBG
sister/NN
chromatids/NNS
together/RB
following/VBG
DNA/NN
replication/NN
,/,
mutational/JJ
inactivation/NN
of/IN
the/DT
cohesin/NN
complex/NN
causes/VBZ
genomic/JJ
instability/NN
and/CC
aneuploidy/NN
during/IN
cell/NN
cycle/NN
progression/NN
in/IN
human/JJ
diseases/NNS
[/(
11/CD
]/)
./.
====================
For/IN
example/NN
,/,
Cornelia/NN
de/FW
Lange/NN
syndrome/NN
,/,
a/DT
rare/JJ
autosomal-dominant/JJ
developmental/JJ
disorder/NN
,/,
is/VBZ
caused/VBN
by/IN
mutation/NN
of/IN
SMC1/NN
,/,
SMC3/NN
,/,
Rad21/NN
,/,
NIPBL/NN
,/,
or/CC
HDAC8/NN
,/,
which/WDT
encode/VBP
core/NN
components/NNS
of/IN
the/DT
cohesin/NN
complex/NN
or/CC
proteins/NNS
that/WDT
interact/VBP
with/IN
this/DT
complex/NN
[/(
66/CD
,/,
67/CD
]/)
./.
====================
Somatic/JJ
mutations/NNS
in/IN
the/DT
cohesin/NN
subunits/NNS
have/VBP
also/RB
been/VBN
frequently/RB
found/VBN
in/IN
several/JJ
different/JJ
human/JJ
tumor/NN
types/NNS
[/(
68–71/CD
]/)
./.
====================
Cohesin/NN
in/IN
transcriptional/JJ
regulation/NN
====================
Although/IN
its/PRP$
role/NN
in/IN
chromatid/JJ
cohesion/NN
during/IN
mitosis/NN
is/VBZ
well/RB
established/VBN
[/(
65/CD
]/)
,/,
cohesin/NN
was/VBD
also/RB
found/VBD
to/TO
bind/VB
thousands/NNS
of/IN
sites/NNS
on/IN
interphase/NN
chromosomes/NNS
[/(
4/CD
]/)
./.
====================
Indeed/RB
,/,
cohesin/NN
interacts/VBZ
with/IN
the/DT
Mediator/NN
complex/NN
,/,
a/DT
transcriptional/JJ
coactivator/NN
[/(
72/CD
]/)
,/,
and/CC
co-occupies/NNS
enhancer/NN
and/CC
promoter/NN
regions/NNS
with/IN
it/PRP
to/TO
regulate/VB
tissue-specific/JJ
gene/NN
expression/NN
[/(
4/CD
]/)
./.
====================
High-throughput/JJ
chromatin/NN
immunoprecipitation–sequence/NN
analyses/NNS
also/RB
revealed/VBD
that/IN
cohesin/NN
remains/VBZ
bound/VBD
at/IN
the/DT
transcription/NN
factor-binding/VBG
sites/NNS
through/IN
replication/NN
to/TO
facilitate/VB
the/DT
re-establishment/JJ
of/IN
transcription/NN
factor/NN
clusters/NNS
after/IN
DNA/NN
replication/NN
and/CC
cell/NN
division/NN
[/(
12/CD
]/)
./.
====================
This/DT
suggests/VBZ
that/IN
the/DT
cohesin/NN
complex/NN
acts/VBZ
as/IN
a/DT
transcriptional/JJ
regulator/NN
in/IN
cellular/JJ
proliferation/NN
,/,
differentiation/NN
,/,
and/CC
development/NN
[/(
8/CD
]/)
./.
====================
Colocalization/NN
of/IN
cohesin/NN
with/IN
CTCF/NN
====================
CTCF/NN
was/VBD
originally/RB
known/VBN
as/IN
a/DT
cohesin/JJ
loading/VBG
factor/NN
[/(
10/CD
,/,
64/CD
]/)
because/IN
genome-wide/NN
studies/NNS
revealed/VBD
that/IN
cohesin/NN
globally/RB
colocalizes/VBZ
extensively/RB
with/IN
CTCF/NN
throughout/IN
the/DT
genome/NN
[/(
61/CD
,/,
62/CD
,/,
73/CD
]/)
./.
====================
However/RB
,/,
CTCF/NN
depletion/NN
did/VBD
not/RB
completely/RB
impair/VB
the/DT
entire/JJ
association/NN
of/IN
cohesin/NN
with/IN
chromatin/NN
[/(
61/CD
,/,
73–75/CD
]/)
./.
====================
Instead/RB
,/,
depletion/NN
of/IN
CTCF/NN
was/VBD
shown/VBN
to/TO
reduce/VB
the/DT
enrichment/JJ
of/IN
cohesin/NN
at/IN
only/RB
a/DT
small/JJ
proportion/NN
of/IN
cohesin-binding/VBG
sites/NNS
[/(
61/CD
,/,
74/CD
,/,
75/CD
]/)
,/,
indicating/VBG
that/IN
CTCF/NN
facilitates/NNS
the/DT
distribution/NN
of/IN
cohesin/NN
to/TO
specific/JJ
sites/NNS
on/IN
chromosomes/NNS
[/(
8/CD
]/)
./.
====================
In/IN
contrast/NN
,/,
the/DT
depletion/NN
of/IN
RAD21/NN
,/,
a/DT
core/NN
subunit/NN
of/IN
the/DT
cohesin/NN
complex/NN
[/(
9/CD
]/)
,/,
does/VBZ
not/RB
disrupt/VB
the/DT
enrichment/JJ
of/IN
CTCF/NN
,/,
suggesting/VBG
that/IN
CTCF/NN
binding/NN
is/VBZ
independent/JJ
of/IN
the/DT
presence/NN
of/IN
cohesin/NN
on/IN
chromatin/NN
[/(
8/CD
]/)
./.
====================
In/IN
this/DT
context/NN
,/,
the/DT
following/VBG
question/NN
arises/VBZ
:/:
What/IN
is/VBZ
the/DT
essential/JJ
role/NN
of/IN
cohesin/NN
at/IN
CTCF-binding/JJ
sites/NNS
?/.
====================
Role/NN
of/IN
CTCF/cohesin/NN
in/IN
genome/NN
folding/VBG
====================
Apart/RB
from/IN
its/PRP$
major/JJ
function/NN
in/IN
sister/NN
chromatid/NN
cohesion/NN
,/,
it/PRP
has/VBZ
recently/RB
been/VBN
shown/VBN
that/IN
cohesin/NN
acts/VBZ
in/IN
concert/NN
with/IN
CTCF/NN
to/TO
affect/VB
higher-order/JJ
chromosome/NN
architecture/NN
by/IN
forming/VBG
long-range/RB
chromosomal/JJ
interactions/NNS
in/IN
many/JJ
developmentally/RB
regulated/VBN
gene/NN
families/NNS
[/(
76/CD
]/)
./.
====================
For/IN
example/NN
,/,
cohesin/NN
has/VBZ
been/VBN
shown/VBN
to/TO
play/VB
a/DT
critical/JJ
role/NN
in/IN
maintaining/VBG
CTCF-mediated/JJ
higher-order/JJ
chromatin/NN
conformation/NN
at/IN
the/DT
β-globin/NN
and/CC
Igf2/H19/NN
loci/NNS
[/(
37/CD
,/,
39/CD
,/,
41/CD
,/,
74/CD
]/)
./.
====================
CTCF/NN
and/CC
cohesin/NN
also/RB
stabilize/VBP
the/DT
rearrangement/NN
of/IN
Igh/JJ
and/CC
T-cell/NN
receptor/NN
loci/NNS
via/IN
long-range/JJ
chromatin/NN
interactions/NNS
[/(
41/CD
,/,
77/CD
,/,
78/CD
]/)
./.
====================
Although/IN
it/PRP
is/VBZ
not/RB
yet/RB
clear/JJ
how/WRB
CTCF/cohesin/NN
mediate/VBP
chromatin/NN
looping/VBG
,/,
CTCF/NN
may/MD
first/JJ
bind/VBP
between/IN
two/CD
CTCF/NN
sites/NNS
and/CC
form/VBP
a/DT
complex/JJ
with/IN
cohesin/NN
through/IN
its/PRP$
C-terminal/JJ
region/NN
[/(
60/CD
,/,
79/CD
,/,
80/CD
]/)
./.
====================
Considering/VBG
the/DT
evidence/NN
that/IN
cohesin/NN
can/MD
tether/VB
DNA/NN
molecules/NNS
together/RB
[/(
81/CD
]/)
,/,
a/DT
study/NN
appeared/VBD
to/TO
show/VB
that/IN
cohesin/NN
stabilized/VBD
long-range/RB
chromatin/NN
interactions/NNS
by/IN
anchoring/VBG
DNA/NN
strands/NNS
together/RB
within/IN
a/DT
closed/JJ
ring/NN
structure/NN
among/IN
CTCF/cohesin/NN
localization/NN
sites/NNS
[/(
11/CD
,/,
64/CD
,/,
76/CD
]/)
./.
====================
Interestingly/RB
,/,
CTCF/cohesin-mediated/JJ
chromatin/NN
looping/VBG
preferentially/RB
occurs/VBZ
between/IN
CTCF/NN
sites/NNS
with/IN
convergent/JJ
CTCF/NN
DNA/NN
motifs/NNS
[/(
82/CD
]/)
./.
====================
Thus/RB
,/,
inverting/VBG
one/CD
site/NN
of/IN
convergent/JJ
CTCF-binding/NN
sites/NNS
changes/NNS
the/DT
chromatin/NN
architecture/NN
and/CC
can/MD
alter/VB
gene/NN
expression/NN
[/(
5/CD
,/,
83/CD
]/)
./.
====================
CTCF/cohesin-mediated/JJ
abnormal/JJ
higher-order/JJ
chromosome/NN
structure/NN
during/IN
tumor/NN
development/NN
====================
Dysregulation/NN
of/IN
the/DT
components/NNS
of/IN
the/DT
cohesin/NN
complex/NN
might/MD
promote/VB
genomic/JJ
instability/NN
by/IN
perturbing/VBG
proper/JJ
long-range/RB
chromatin/NN
interactions/NNS
,/,
which/WDT
can/MD
confer/VB
the/DT
spatial/JJ
proximity/NN
required/VBN
for/IN
the/DT
rejoining/VBG
of/IN
DSBs/NNS
during/IN
chromosomal/JJ
rearrangement/NN
[/(
18/CD
]/)
./.
====================
More/RBR
recent/JJ
studies/NNS
support/VBP
a/DT
similar/JJ
role/NN
for/IN
the/DT
CTCF/cohesin-mediated/JJ
chromatin/NN
loop/NN
as/IN
a/DT
regulator/NN
of/IN
genome/NN
integrity/NN
[/(
84/CD
]/)
./.
====================
They/PRP
found/VBN
that/IN
chromosome/NN
loop/NN
anchors/NNS
bound/VBD
by/IN
CTCF/NN
and/CC
cohesin/NN
are/VBP
vulnerable/JJ
to/TO
continuous/JJ
DNA/NN
breaks/NNS
and/CC
translocation/NN
breakpoint/NN
regions/NNS
in/IN
various/JJ
cancers/NNS
are/VBP
enriched/VBN
at/IN
these/DT
loop/NN
anchors/NNS
[/(
84/CD
]/)
./.
====================
Similarly/RB
,/,
we/PRP
found/VBD
that/IN
cohesin-mediated/VBD
chromatin/NN
organization/NN
and/CC
DNA/NN
replication/NN
are/VBP
important/JJ
for/IN
stabilizing/VBG
gene/NN
amplification/NN
in/IN
cancer/NN
cells/NNS
with/IN
chromosomal/JJ
instability/NN
(/(
Fig/NN
./.
====================
5/CD
)/)
[/(
85/CD
]/)
./.
====================
Although/IN
a/DT
high/JJ
frequency/NN
of/IN
recurrent/JJ
mutations/NNS
and/CC
deletions/NNS
of/IN
the/DT
components/NNS
of/IN
the/DT
cohesin/NN
complex/NN
was/VBD
identified/VBN
in/IN
human/JJ
diseases/NNS
[/(
70/CD
,/,
71/CD
,/,
86/CD
]/)
,/,
aberrant/JJ
overexpression/NN
of/IN
the/DT
cohesin/NN
complex/NN
[/(
9/CD
]/)
was/VBD
also/RB
frequently/RB
detected/VBN
in/IN
various/JJ
human/JJ
malignancies/NNS
[/(
85/CD
]/)
./.
====================
Interestingly/RB
,/,
we/PRP
found/VBD
that/IN
overexpression/NN
of/IN
the/DT
cohesin/NN
complex/NN
in/IN
mesenchymal/JJ
cancer/NN
cells/NNS
induces/VBZ
mesenchymal/JJ
to/TO
epithelial/JJ
transition–specific/JJ
expression/NN
patterns/NNS
and/CC
dynamic/JJ
cohesin-mediated/JJ
chromatin/NN
structures/NNS
are/VBP
responsible/JJ
for/IN
the/DT
initiation/NN
and/CC
regulation/NN
of/IN
essential/JJ
epithelial/JJ
to/TO
mesenchymal/JJ
transition–related/VBN
cell/NN
fate/NN
changes/NNS
in/IN
human/JJ
cancer/NN
(/(
Fig/NN
./.
====================
6/CD
)/)
[/(
87/CD
]/)
./.
====================
An/DT
increasing/VBG
amount/NN
of/IN
recent/JJ
evidence/NN
has/VBZ
indicated/VBN
that/IN
CTCF/NN
and/CC
cohesin/NN
are/VBP
enriched/VBN
at/IN
TADs/NNS
[/(
6/CD
,/,
15/CD
]/)
./.
====================
Accordingly/RB
,/,
cohesin-associated/VBD
CTCF/NN
loops/NNS
occur/VBP
within/IN
TADs/NNS
and/CC
enhancers/NNS
generally/RB
interact/VBP
with/IN
genes/NNS
within/IN
these/DT
loops/NNS
[/(
8/CD
]/)
./.
====================
Interestingly/RB
,/,
recurrent/JJ
mutations/NNS
occur/VBP
frequently/RB
within/IN
CTCF/NN
anchor/NN
sites/NNS
adjacent/JJ
to/TO
oncogenes/NNS
or/CC
cancer-associated/JJ
genes/NNS
[/(
55/CD
]/)
./.
====================
Mutation/NN
in/IN
the/DT
isocitrate/NN
dehydrogenase/NN
(/(
IDH/NN
)/)
gene/NN
promotes/VBZ
susceptibility/NN
of/IN
the/DT
CTCF-binding/JJ
sites/NNS
to/TO
DNA/NN
methylation/NN
and/CC
the/DT
loss/NN
of/IN
CTCF/NN
binding/NN
resulting/VBG
in/IN
the/DT
disruption/NN
of/IN
TAD/NN
organization/NN
in/IN
human/JJ
gliomas/NNS
[/(
88/CD
]/)
./.
====================
Somatic/JJ
mutations/NNS
change/NN
oncogene-containing/VBG
insulated/JJ
neighborhoods/NNS
,/,
thereby/RB
allowing/VBG
improper/NN
activation/NN
of/IN
proto-oncogenes/NNS
by/IN
enhancers/NNS
located/JJ
within/IN
different/JJ
TADs/NNS
[/(
89/CD
]/)
./.
====================
Furthermore/RB
,/,
disruption/NN
of/IN
CTCF-mediated/JJ
TAD/NN
formation/NN
by/IN
human/JJ
noncoding/JJ
disease/NN
variants/NNS
elicits/VBZ
pathogenic/JJ
phenotypes/NNS
,/,
providing/VBG
the/DT
mechanistic/JJ
linkage/NN
between/IN
spatial/JJ
genomic/JJ
organization/NN
and/CC
genetic/JJ
alterations/NNS
that/IN
influence/VBP
gene/NN
expression/NN
[/(
90/CD
]/)
./.
====================
Over/RB
the/DT
past/NN
few/JJ
years/NNS
,/,
substantial/JJ
progress/NN
has/VBZ
been/VBN
made/VBN
in/IN
understanding/VBG
three-dimensional/JJ
genome/NN
architecture/NN
./.
====================
However/RB
,/,
its/PRP$
role/NN
in/IN
cancer/NN
remains/VBZ
incompletely/RB
understood/VBN
./.
====================
An/DT
intriguing/JJ
issue/NN
in/IN
this/DT
context/NN
is/VBZ
that/IN
,/,
although/IN
most/JJS
topological/JJ
boundaries/NNS
are/VBP
enriched/VBN
for/IN
the/DT
binding/VBG
of/IN
CTCF/NN
,/,
only/RB
15/CD
%/NN
of/IN
CTCF-binding/JJ
sites/NNS
are/VBP
located/JJ
within/IN
TAD/NN
boundaries/NNS
[/(
15/CD
]/)
,/,
suggesting/VBG
that/IN
additional/JJ
factors/NNS
other/JJ
than/IN
the/DT
CTCF/cohesin/NN
complex/NN
might/MD
be/VB
required/VBN
to/TO
establish/VB
the/DT
topological/JJ
domain/NN
structure/NN
of/IN
the/DT
genome/NN
[/(
17/CD
]/)
./.
====================
Further/RB
work/NN
is/VBZ
needed/VBN
to/TO
clarify/VB
the/DT
mechanisms/NNS
underlying/VBG
this/DT
level/NN
of/IN
chromosomal/JJ
organization/NN
,/,
and/CC
to/TO
what/DT
extent/NN
it/PRP
generally/RB
contributes/VBZ
to/TO
the/DT
transcriptional/JJ
regulation/NN
of/IN
genes/NNS
during/IN
tumorigenesis/NN
./.
====================
While/IN
increasing/VBG
evidence/NN
has/VBZ
recently/RB
indicated/VBD
that/IN
enhancers/NNS
are/VBP
located/JJ
near/RB
oncogenic/JJ
genes/NNS
and/CC
exhibit/VBP
a/DT
large/JJ
number/NN
of/IN
variants/NNS
associated/VBN
with/IN
diseases/NNS
[/(
91/CD
]/)
,/,
a/DT
more/RBR
complete/JJ
understanding/NN
of/IN
how/WRB
epigenetic/JJ
alteration/NN
of/IN
enhancers/NNS
directly/RB
participates/VBZ
in/IN
the/DT
development/NN
and/CC
onset/NN
of/IN
genome/NN
reorganization/NN
during/IN
tumor/NN
progression/NN
remains/VBZ
to/TO
be/VB
obtained/VBN
./.
====================
Based/VBN
on/IN
this/DT
point/NN
,/,
recently/RB
developed/VBD
CRISPR/Cas9-based/JJ
epigenome-editing/VBG
technology/NN
has/VBZ
attracted/VBN
considerable/JJ
interest/NN
because/IN
this/DT
approach/NN
can/MD
acutely/RB
modify/VB
the/DT
epigenetic/JJ
landscape/NN
of/IN
specific/JJ
regulatory/JJ
elements/NNS
[/(
92/CD
]/)
./.
====================
For/IN
example/NN
,/,
targeted/VBN
editing/VBG
of/IN
the/DT
DNA/NN
methylation/NN
status/NN
of/IN
CTCF-binding/JJ
sites/NNS
changes/NNS
CTCT/NN
recruitment/NN
,/,
thereby/RB
altering/VBG
the/DT
expression/NN
of/IN
genes/NNS
by/IN
influencing/VBG
the/DT
organization/NN
of/IN
higher-order/JJ
chromatin/NN
structures/NNS
[/(
93/CD
]/)
./.
====================
Furthermore/RB
,/,
a/DT
high-throughput/JJ
CRISPR/NN
activation/NN
system/NN
was/VBD
also/RB
used/VBN
to/TO
reveal/VB
how/WRB
noncoding/JJ
variation/NN
associated/VBN
with/IN
human/JJ
immune/JJ
dysfunction/NN
alters/VBZ
stimulation-dependent/JJ
enhancer/NN
function/NN
[/(
94/CD
]/)
./.
====================
Thus/RB
,/,
highly/RB
specific/JJ
CRISPR/Cas9-based/JJ
epigenome-editing/VBG
technology/NN
may/MD
serve/VB
as/IN
an/DT
attractive/JJ
treatment/NN
option/NN
for/IN
epigenetic-based/JJ
cancer/NN
therapies/NNS
in/IN
the/DT
coming/VBG
years/NNS
./.
====================
The/DT
spatial/JJ
folding/VBG
of/IN
chromosomes/NNS
in/IN
the/DT
nucleus/NN
./.
====================
TADs/NNS
,/,
topologically/RB
associated/VBN
domains/NNS
./.
====================
A/DT
schematic/JJ
representation/NN
of/IN
CCCTC-binding/JJ
factor/NN
(/(
CTCF/NN
)/)
–mediated/JJ
looping/VBG
structure/NN
./.
====================
TFs/NNS
,/,
transcription/NN
factors/NNS
./.
====================
(/(
A/NN
,/,
B/NN
)/)
Methylation-sensitive/JJ
binding/NN
of/IN
CCCTC-binding/JJ
factor/NN
(/(
CTCF/NN
)/)
./.
====================
A/DT
schematic/JJ
representation/NN
of/IN
the/DT
cohesin/NN
complex/NN
./.
====================
Smc/JJ
,/,
structural/JJ
maintenance/NN
of/IN
chromosomes/NNS
;/:
Stag/NN
,/,
stromal/JJ
antigen/NN
./.
====================
Cohesin-mediated/JJ
higher-order/JJ
chromatin/NN
structures/NNS
are/VBP
important/JJ
for/IN
the/DT
expression/NN
and/CC
presence/NN
of/IN
high-level/JJ
gene/NN
amplification/NN
in/IN
cancer/NN
cells/NNS
with/IN
chromosomal/JJ
instability/NN
./.
====================
HSRs/NNS
,/,
homogeneously/RB
staining/NN
regions/NNS
;/:
DMs/NNS
,/,
extrachromosomal/JJ
double/JJ
minutes/NNS
./.
====================
Cohesin-mediated/JJ
dynamic/JJ
chromatin/NN
architecture/NN
of/IN
the/DT
TGFB1/NN
and/CC
ITGA5/NN
genes/NNS
associated/VBN
with/IN
epithelial/JJ
to/TO
mesenchymal/JJ
transition/NN
(/(
EMT/NN
)/)
plasticity/NN
./.
====================
MET/NN
,/,
mesenchymal/JJ
to/TO
epithelial/JJ
transition/NN
./.
====================
